BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26134229)

  • 21. A method for deriving a 4D-interpolated balanced planning target for mobile tumor radiotherapy.
    Roland T; Hales R; McNutt T; Wong J; Simari P; Tryggestad E
    Med Phys; 2012 Jan; 39(1):195-205. PubMed ID: 22225288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Image-guided respiratory-gated lung stereotactic body radiotherapy: which target definition is optimal?
    Zhao B; Yang Y; Li T; Li X; Heron DE; Huq MS
    Med Phys; 2009 Jun; 36(6):2248-57. PubMed ID: 19610314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy.
    Jin JY; Ajlouni M; Chen Q; Yin FF; Movsas B
    Radiother Oncol; 2006 Feb; 78(2):177-84. PubMed ID: 16376444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of internal target volume from a single positron emission tomography/computed tomography scan in lung cancer.
    Chang G; Chang T; Pan T; Clark JW; Mawlawi OR
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):459-66. PubMed ID: 22197228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of FDG-PET to guide dose prescription heterogeneity in stereotactic body radiation therapy for lung cancers with volumetric modulated arc therapy: a feasibility study.
    de Figueiredo BH; Antoine M; Trouette R; Lagarde P; Petit A; Lamare F; Hatt M; Fernandez P
    Radiat Oncol; 2014 Dec; 9():300. PubMed ID: 25534014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generating lung tumor internal target volumes from 4D-PET maximum intensity projections.
    Lamb JM; Robinson C; Bradley J; Laforest R; Dehdashti F; White BM; Wuenschel S; Low DA
    Med Phys; 2011 Oct; 38(10):5732-7. PubMed ID: 21992387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor control probability and the utility of 4D vs 3D dose calculations for stereotactic body radiotherapy for lung cancer.
    Valdes G; Robinson C; Lee P; Morel D; Low D; Iwamoto KS; Lamb JM
    Med Dosim; 2015; 40(1):64-9. PubMed ID: 25542785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
    Flampouri S; Jiang SB; Sharp GC; Wolfgang J; Patel AA; Choi NC
    Phys Med Biol; 2006 Jun; 51(11):2763-79. PubMed ID: 16723765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography.
    Hanna GG; van Sörnsen de Koste JR; Dahele MR; Carson KJ; Haasbeek CJ; Migchielsen R; Hounsell AR; Senan S
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):e71-80. PubMed ID: 22445302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
    Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
    Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy.
    Oechsner M; Odersky L; Berndt J; Combs SE; Wilkens JJ; Duma MN
    Radiat Oncol; 2015 Dec; 10():249. PubMed ID: 26626865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.
    Bowen SR; Nyflot MJ; Herrmann C; Groh CM; Meyer J; Wollenweber SD; Stearns CW; Kinahan PE; Sandison GA
    Phys Med Biol; 2015 May; 60(9):3731-46. PubMed ID: 25884892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four-dimensional treatment planning for stereotactic body radiotherapy.
    Guckenberger M; Wilbert J; Krieger T; Richter A; Baier K; Meyer J; Flentje M
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):276-85. PubMed ID: 17707282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Respiratory-gated Positron Emission Tomography/Computed Tomography for Radiotherapy Planning in Patients with Lung Carcinoma - A Systematic Review.
    Frood R; Prestwich R; Tsoumpas C; Murray P; Franks K; Scarsbrook A
    Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):225-232. PubMed ID: 29397271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of planning target volume margin when using a robotic radiosurgery system to treat lung tumors with spine tracking.
    James J; Swanson C; Lynch B; Wang B; Dunlap NE
    Pract Radiat Oncol; 2015; 5(4):e337-43. PubMed ID: 25532489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simulation of dosimetric consequences of 4D-CT-based motion margin estimation for proton radiotherapy using patient tumor motion data.
    Koybasi O; Mishra P; St James S; Lewis JH; Seco J
    Phys Med Biol; 2014 Feb; 59(4):853-67. PubMed ID: 24487573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric analysis of respiratory-gated radiotherapy for hepatocellular carcinoma.
    Xi M; Zhang L; Liu MZ; Deng XW; Huang XY; Liu H
    Med Dosim; 2011; 36(2):213-8. PubMed ID: 20570128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.